Cardiovascular disease is the leading cause of death worldwide, and the identification
of modifiable risk factors potentially implicated in the onset and progression of
cardiovascular disease therefore appears of paramount importance in this setting.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Human serum albumin in cardiovascular diseases.Eur J Intern Med. 2018; 52: 8-12
- Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome.Int J Epidemiol. 2014; 43: 922-929
- Plasma albumin and incident cardiovascular disease: results from the CGPS and an updated meta-analysis.Arterioscler Thromb Vasc Biol. 2020; 40: 473-482
- Serum albumin and atrial fibrillation: insights from epidemiological and Mendelian randomization studies.Eur J Epidemiol. 2020; 35: 113-122
- Decreased serum albumin predicts hypertension in a Japanese health screening population.Intern Med. 2014; 53: 655-660
- Clinical characteristics, management and outcomes of japanese patients hospitalized for heart failure with preserved ejection fraction –a report from the japanese heart failure syndrome with preserved ejection fraction (JASPER) registry.Circ J. 2018; 82: 1534-1545
- The role of oxidative stress in the pathophysiology of hypertension.Hypertens Res. 2011; 34: 431-440
- Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials.Ann Surg. 2003; 237: 319-334
- Nutritional intervention incorporating expedited 10g protein counter (EP-10) to improve the albumin and transferrin of chronic hemodialysis patients.ISRN Nutr. 2012; 2013396570
Article info
Publication history
Published online: July 27, 2020
Accepted:
July 23,
2020
Received:
July 19,
2020
Identification
Copyright
© 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
